RETA

Reata Pharmaceuticals, Inc. Class A Common Stock
RETA

Overview Fund Activity
Delisted

RETA was delisted on the 25th of September, 2023.

Back to rankings

168 hedge funds and large institutions have $1.14B invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2022 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 55 increasing their positions, 44 reducing their positions, and 25 closing their positions.

Holders
168
Holders Change
+9
Holders Change %
+5.66%
% of All Funds
2.71%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
36
Increased
55
Reduced
44
Closed
25
Calls
$22.6M
Puts
$32.3M
Net Calls
-$9.66M
Net Calls Change
-$27.6M

Top Buyers

1
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$49.6M
2
FLAM
2
First Light Asset Management
Minnesota
$78.4M
3
FAM
3
Fred Alger Management
New York
$57.3M
4
Deutsche Bank
4
Deutsche Bank
Germany
$56.7M
5
Morgan Stanley
5
Morgan Stanley
New York
$27.9M

Top Sellers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$0
2
CCM
2
Camber Capital Management
Massachusetts
$0
3
GCM
3
Graham Capital Management
Connecticut
$899K
4
GTC
4
Ghost Tree Capital
New York
$19M
5
Franklin Resources
5
Franklin Resources
California
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
BBA
26
Baker Bros. Advisors
New York
$8.51M – – –
Voloridge Investment Management
27
Voloridge Investment Management
Florida
$8.28M -$3.87M -101,933 -32%
Charles Schwab
28
Charles Schwab
California
$7.83M +$131K +3,461 +2%
Marshall Wace
29
Marshall Wace
United Kingdom
$7.8M +$7.35M +193,342 +1,611%
Norges Bank
30
Norges Bank
Norway
$7.8M +$250K +6,589 +3%
Bank of America
31
Bank of America
North Carolina
$7.71M +$1.23M +32,475 +19%
MB
32
MPM BioImpact
Massachusetts
$7.38M +$575K +15,123 +8%
LGM
33
Logos Global Management
California
$6.84M +$6.84M +180,000 New
JPMorgan Chase & Co
34
JPMorgan Chase & Co
New York
$6.36M +$1.31M +34,356 +26%
Two Sigma Investments
35
Two Sigma Investments
New York
$5.53M +$3.7M +97,329 +202%
TLP
36
Tri Locum Partners
New York
$5.37M +$5.37M +141,466 New
AllianceBernstein
37
AllianceBernstein
Tennessee
$4.31M +$2.98M +78,439 +225%
Nuveen Asset Management
38
Nuveen Asset Management
Illinois
$4.07M -$126K -3,318 -3%
Bank of New York Mellon
39
Bank of New York Mellon
New York
$3.87M +$97.7K +2,573 +3%
Jacobs Levy Equity Management
40
Jacobs Levy Equity Management
New Jersey
$3.64M -$845K -22,247 -19%
Invesco
41
Invesco
Georgia
$3.42M +$2.39M +62,997 +232%
Squarepoint
42
Squarepoint
New York
$3.39M +$1.83M +48,065 +117%
IHAM
43
Integral Health Asset Management
New York
$3.23M +$3.23M +85,000 New
Citadel Advisors
44
Citadel Advisors
Florida
$2.84M -$3.31M -87,179 -54%
Thrivent Financial for Lutherans
45
Thrivent Financial for Lutherans
Minnesota
$2.79M +$1.37M +36,156 +97%
Ensign Peak Advisors
46
Ensign Peak Advisors
Utah
$2.69M -$274K -7,200 -9%
Luther King Capital Management (LKCM)
47
Luther King Capital Management (LKCM)
Texas
$2.49M – – –
Swiss National Bank
48
Swiss National Bank
Switzerland
$2.46M +$57K +1,500 +2%
DFO
49
Duquesne Family Office
New York
$2.24M – – –
HWAM
50
Hennion & Walsh Asset Management
New Jersey
$2.21M -$483K -12,710 -18%
1
2
3 4 5